Silicone splint aims to prevent prolapse from returning after surgery

NCT ID NCT05812859

Ongoing Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests a custom silicone vaginal splint used daily for 10 weeks after reconstructive surgery for pelvic organ prolapse. The device is placed in the morning and removed at night to support healing. Researchers will compare prolapse recurrence rates and symptoms between women who use the splint and those who receive standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vaginal orthosis (silicone splint)
What this could lead to: If it works, this device could improve healing and lower the chance of prolapse returning after surgery.
What could go wrong: This is a small early study with only 30 participants, so results may not apply widely. The device may be uncomfortable or not reduce recurrence as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PELVIC ORGAN PROLAPSE

Contacts and locations

Show contact details

Locations

UAB Hospital

Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.